[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600387":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":26,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":26,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":26,"overallStatus":76,"whyStopped":26,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Khyber Teaching Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"TCDO + Standard Wound Care","EXPERIMENTAL","Participants in this group will receive topical Tetrachlorodecaoxide (TCDO, also known as Oxoferin®) drops applied directly to the wound bed once daily for 21 consecutive days, or until satisfactory healing is achieved. This will be administered alongside standard wound care practices, including saline irrigation, wound debridement, antibiotics as necessary, and sterile dressing.",[13,14],"Drug: Topical Tetrachlorodecaoxide (TCDO\u002FOxoferin)","Other: Standard Wound Care",{"label":16,"type":17,"description":18,"interventionNames":19},"Standard Wound Care Only","ACTIVE_COMPARATOR","Participants in this group will receive standard wound care practices, including saline irrigation, wound debridement, antibiotics as necessary, and sterile dressing, without the use of TCDO.",[14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Topical Tetrachlorodecaoxide (TCDO\u002FOxoferin)","Topical Tetrachlorodecaoxide (TCDO), a solution with antimicrobial and oxygen-releasing properties, will be applied once daily to the wound bed for 21 consecutive days or until satisfactory healing.",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Standard Wound Care","Standard wound care includes saline irrigation, wound debridement, antibiotic administration as necessary, and sterile dressing. Provided to all participants.",[16,9],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Fazeelat Bibi, MBBS, MRCS part A","CONTACT","+923059501376","fazeelat5740@gmail.com",[38],{"facility":39,"status":26,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Khyber Teaching Hospital, MTI KTH Peshawar","Peshawar","Khyber Pakhtunkhwa","25000","Pakistan","PK",{"type":46,"coordinates":47},"Point",[48,49],71.57849,34.008,{"lat":49,"lon":48},[52],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","Fazeelat Bibi","General surgery resident, Khyber Teaching Hospital MTI-KTH Peshawar","100600387","efficacy-of-tetrachlorodecaoxide-tcdo-drops-in-chronic-wound-healing-100600387",false,"NCT07096830","Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing","Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing: Insights From a Randomized Controlled Trial","TCDO-Wound","Inclusion Criteria:\n\n* Adults \\> 18 years diagnosed with chronic wounds (duration \\> 6 weeks)\n* Wound size between 5 and 10 cm²\n* Adequate perfusion:\n* Ankle-Brachial Pressure Index (ABPI) \\> 0.8 for venous leg ulcers\n* Palpable pulses for diabetic foot ulcers\n\nExclusion Criteria:\n\n* Patients receiving immunosuppressive therapy or corticosteroids\n* Presence of malignancy\n* Patients who do not provide informed consent","ALL","18 Years",{"count":68,"type":69},66,"ESTIMATED","INTERVENTIONAL",[72],"NA","This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.",[75],"Chronic Wound Care","NOT_YET_RECRUITING","2025-07-31",{"date":79,"type":80},"2025-08-05","ACTUAL",{"date":82,"type":69},"2025-08-30",{"date":84,"type":69},"2026-08-30",{"name":55,"class":6},1]